The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thin Film Drug Market Research Report 2025
Synopsis
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The global Thin Film Drug market was valued at US$ 7709 million in 2023 and is anticipated to reach US$ 8696.3 million by 2030, witnessing a CAGR of 1.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Thin Film Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thin Film Drug.
Report Scope
The Thin Film Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thin Film Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thin Film Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx
APR
Segment by Type
Oral Thin Film
Transdermal Thin Film
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thin Film Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The global Thin Film Drug market was valued at US$ 7709 million in 2023 and is anticipated to reach US$ 8696.3 million by 2030, witnessing a CAGR of 1.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Thin Film Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thin Film Drug.
Report Scope
The Thin Film Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thin Film Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thin Film Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx
APR
Segment by Type
Oral Thin Film
Transdermal Thin Film
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thin Film Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thin Film Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Thin Film
1.2.3 Transdermal Thin Film
1.2.4 Others
1.3 Market by Application
1.3.1 Global Thin Film Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thin Film Drug Market Perspective (2019-2030)
2.2 Thin Film Drug Growth Trends by Region
2.2.1 Global Thin Film Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Thin Film Drug Historic Market Size by Region (2019-2024)
2.2.3 Thin Film Drug Forecasted Market Size by Region (2025-2030)
2.3 Thin Film Drug Market Dynamics
2.3.1 Thin Film Drug Industry Trends
2.3.2 Thin Film Drug Market Drivers
2.3.3 Thin Film Drug Market Challenges
2.3.4 Thin Film Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thin Film Drug Players by Revenue
3.1.1 Global Top Thin Film Drug Players by Revenue (2019-2024)
3.1.2 Global Thin Film Drug Revenue Market Share by Players (2019-2024)
3.2 Global Thin Film Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thin Film Drug Revenue
3.4 Global Thin Film Drug Market Concentration Ratio
3.4.1 Global Thin Film Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thin Film Drug Revenue in 2023
3.5 Thin Film Drug Key Players Head office and Area Served
3.6 Key Players Thin Film Drug Product Solution and Service
3.7 Date of Enter into Thin Film Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thin Film Drug Breakdown Data by Type
4.1 Global Thin Film Drug Historic Market Size by Type (2019-2024)
4.2 Global Thin Film Drug Forecasted Market Size by Type (2025-2030)
5 Thin Film Drug Breakdown Data by Application
5.1 Global Thin Film Drug Historic Market Size by Application (2019-2024)
5.2 Global Thin Film Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Thin Film Drug Market Size (2019-2030)
6.2 North America Thin Film Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Thin Film Drug Market Size by Country (2019-2024)
6.4 North America Thin Film Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thin Film Drug Market Size (2019-2030)
7.2 Europe Thin Film Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Thin Film Drug Market Size by Country (2019-2024)
7.4 Europe Thin Film Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thin Film Drug Market Size (2019-2030)
8.2 Asia-Pacific Thin Film Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Thin Film Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Thin Film Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thin Film Drug Market Size (2019-2030)
9.2 Latin America Thin Film Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Thin Film Drug Market Size by Country (2019-2024)
9.4 Latin America Thin Film Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thin Film Drug Market Size (2019-2030)
10.2 Middle East & Africa Thin Film Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Thin Film Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Thin Film Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Thin Film Drug Introduction
11.1.4 GSK Revenue in Thin Film Drug Business (2019-2024)
11.1.5 GSK Recent Development
11.2 LTS
11.2.1 LTS Company Detail
11.2.2 LTS Business Overview
11.2.3 LTS Thin Film Drug Introduction
11.2.4 LTS Revenue in Thin Film Drug Business (2019-2024)
11.2.5 LTS Recent Development
11.3 J&J
11.3.1 J&J Company Detail
11.3.2 J&J Business Overview
11.3.3 J&J Thin Film Drug Introduction
11.3.4 J&J Revenue in Thin Film Drug Business (2019-2024)
11.3.5 J&J Recent Development
11.4 Indivior
11.4.1 Indivior Company Detail
11.4.2 Indivior Business Overview
11.4.3 Indivior Thin Film Drug Introduction
11.4.4 Indivior Revenue in Thin Film Drug Business (2019-2024)
11.4.5 Indivior Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Thin Film Drug Introduction
11.5.4 Pfizer Revenue in Thin Film Drug Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Thin Film Drug Introduction
11.6.4 Sanofi Revenue in Thin Film Drug Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Church & Dwight
11.7.1 Church & Dwight Company Detail
11.7.2 Church & Dwight Business Overview
11.7.3 Church & Dwight Thin Film Drug Introduction
11.7.4 Church & Dwight Revenue in Thin Film Drug Business (2019-2024)
11.7.5 Church & Dwight Recent Development
11.8 tesa Labtec
11.8.1 tesa Labtec Company Detail
11.8.2 tesa Labtec Business Overview
11.8.3 tesa Labtec Thin Film Drug Introduction
11.8.4 tesa Labtec Revenue in Thin Film Drug Business (2019-2024)
11.8.5 tesa Labtec Recent Development
11.9 Tapemark
11.9.1 Tapemark Company Detail
11.9.2 Tapemark Business Overview
11.9.3 Tapemark Thin Film Drug Introduction
11.9.4 Tapemark Revenue in Thin Film Drug Business (2019-2024)
11.9.5 Tapemark Recent Development
11.10 Prestige Bands
11.10.1 Prestige Bands Company Detail
11.10.2 Prestige Bands Business Overview
11.10.3 Prestige Bands Thin Film Drug Introduction
11.10.4 Prestige Bands Revenue in Thin Film Drug Business (2019-2024)
11.10.5 Prestige Bands Recent Development
11.11 Sun Pharma
11.11.1 Sun Pharma Company Detail
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Thin Film Drug Introduction
11.11.4 Sun Pharma Revenue in Thin Film Drug Business (2019-2024)
11.11.5 Sun Pharma Recent Development
11.12 MonoSol
11.12.1 MonoSol Company Detail
11.12.2 MonoSol Business Overview
11.12.3 MonoSol Thin Film Drug Introduction
11.12.4 MonoSol Revenue in Thin Film Drug Business (2019-2024)
11.12.5 MonoSol Recent Development
11.13 BioDelivery
11.13.1 BioDelivery Company Detail
11.13.2 BioDelivery Business Overview
11.13.3 BioDelivery Thin Film Drug Introduction
11.13.4 BioDelivery Revenue in Thin Film Drug Business (2019-2024)
11.13.5 BioDelivery Recent Development
11.14 Arx
11.14.1 Arx Company Detail
11.14.2 Arx Business Overview
11.14.3 Arx Thin Film Drug Introduction
11.14.4 Arx Revenue in Thin Film Drug Business (2019-2024)
11.14.5 Arx Recent Development
11.15 ZIM
11.15.1 ZIM Company Detail
11.15.2 ZIM Business Overview
11.15.3 ZIM Thin Film Drug Introduction
11.15.4 ZIM Revenue in Thin Film Drug Business (2019-2024)
11.15.5 ZIM Recent Development
11.16 NAL Pharma
11.16.1 NAL Pharma Company Detail
11.16.2 NAL Pharma Business Overview
11.16.3 NAL Pharma Thin Film Drug Introduction
11.16.4 NAL Pharma Revenue in Thin Film Drug Business (2019-2024)
11.16.5 NAL Pharma Recent Development
11.17 AdhexPharma
11.17.1 AdhexPharma Company Detail
11.17.2 AdhexPharma Business Overview
11.17.3 AdhexPharma Thin Film Drug Introduction
11.17.4 AdhexPharma Revenue in Thin Film Drug Business (2019-2024)
11.17.5 AdhexPharma Recent Development
11.18 Aavishkar
11.18.1 Aavishkar Company Detail
11.18.2 Aavishkar Business Overview
11.18.3 Aavishkar Thin Film Drug Introduction
11.18.4 Aavishkar Revenue in Thin Film Drug Business (2019-2024)
11.18.5 Aavishkar Recent Development
11.19 IntelGenx
11.19.1 IntelGenx Company Detail
11.19.2 IntelGenx Business Overview
11.19.3 IntelGenx Thin Film Drug Introduction
11.19.4 IntelGenx Revenue in Thin Film Drug Business (2019-2024)
11.19.5 IntelGenx Recent Development
11.20 APR
11.20.1 APR Company Detail
11.20.2 APR Business Overview
11.20.3 APR Thin Film Drug Introduction
11.20.4 APR Revenue in Thin Film Drug Business (2019-2024)
11.20.5 APR Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
